Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

NCT04612894 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: Camrelizumab and Apatinib
PROCEDURE: surgery
PROCEDURE: core needle biopsy

Sponsor

Fudan University